The effect of hypothalamo-pituitary disconnection on the renin-angiotensin system in the late-gestation fetal sheep.
The activity of the renin-angiotensin system (RAS) increases significantly in the late-gestation fetal sheep. Fetal cortisol is also increased during this time, and it is thought that the increase in cortisol may modulate the RAS changes. Previous studies have examined the effects of cortisol infusion on RAS activity, but the effects of blocking the peripartum increase in cortisol concentrations on the developmental changes in the RAS are not known. Therefore, we utilized the technique of hypothalamic-pituitary disconnection (HPD), which prevents the cortisol surge from occurring, to investigate the importance of the late-gestation increase in cortisol on the ontogenic changes in RAS activity. HPD of fetal sheep was performed at 120 days of gestational age (dGA), and fetuses were delivered between 135 and 139 dGA. Control fetuses were sham operated. HPD blocked the late-gestation cortisol increase but did not alter renal renin mRNA, renal renin or prorenin protein content, nor plasma renin levels compared with sham operated. However, HPD fetuses had increased ANG II receptor subtype 1 (AT1) mRNA and protein expression in the kidney and lungs. ANG II receptor subtype 2 (AT2) expression was not altered in these tissues at either mRNA or protein level. HPD did not change AT1 or AT2 mRNA in the left ventricle but did result in decreased protein levels for both receptors. These studies demonstrate that blockade of the naturally occurring increase in fetal cortisol concentration in late gestation is associated with tissue-specific alterations in expression of AT1 and AT2 receptors. These changes may impact on fetal tissue maturation and hence have consequences in postnatal life.
Chen
Kai
K
Dept. of Obstetrics and Gynecology, Wake Forest Univ. School of Medicine, Winston-Salem, NC 27157-1066, USA.
Carey
Luke C
LC
Liu
Jingfang
J
Valego
Nancy K
NK
Tatter
Stephen B
SB
Rose
James C
JC
D000818:Animals; D003714:Denervation; D005260:Female; D047109:Fetal Development / Q000502:physiology*; D018507:Gene Expression Regulation, Developmental; D005865:Gestational Age; D006854:Hydrocortisone / Q000097:blood*; D007030:Hypothalamo-Hypophyseal System / Q000196:embryology* / Q000502:physiology; D011247:Pregnancy; D011945:Receptors, Angiotensin / Q000502:physiology; D012083:Renin / Q000097:blood; D012084:Renin-Angiotensin System / Q000502:physiology*; D012756:Sheep; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D011945:Receptors, Angiotensin; D014284:Triiodothyronine; D012083:Renin; D013974:Thyroxine; D006854:Hydrocortisone